| Variables | Impaired LV GLS | Normal LV GLS | Crude OR (95% CI) | Crude p value | Adjusted OR (95% CI)£ | Adjusted p value£ |
| Age, years (Mean ± SD) | 60.2 ± 12.0 | 55.2 ± 11.2 | NA | 0.042 | NA | 0.961 |
| Female sex | 26 (63.4) | 33 (61.1) | 1.1 (0.5 - 2.6) | 0.819 |
|
|
| Obesity | 22 (53.7) | 12 (22.2) | 4.1 (1.7 - 9.8) | 0.002 | 4 (1.5 - 10.6) | 0.005 |
| Current smoking | 1 (2.4) | 1 (1.9) | 1.3 (0.08 - 21.8) | 1.000 |
|
|
| Dyslipidemia | 13 (31.7) | 12 (22.2) | 1.6 (0.6 - 4.1) | 0.298 |
|
|
| Hypertension | 29 (70.7) | 25 (46.3) | 2.8 (1.2 - 6.6) | 0.017 | 1.7 (0.6 - 5.2) | 0.301 |
| DM Duration* | 9 [3 - 15] | 5 [1 - 10] | NA | 0.047 | NA | 0.189 |
| Dilated left atrium | 3 (7.3) | 2 (3.7) | 2.1 (0.3 - 12.9) | 0.649 |
|
|
| cLVH | 8 (19.5) | 4 (7.4) | 3.03 (0.8 - 10.9) | 0.079 |
|
|
| LV Remodelling | 19 (39) | 16 (29.6) | 1.5 (0.6 - 3.6) | 0.337 |
|
|
| Diastolic dysfunction | 28 (68.3) | 21 (38.9) | 3.4 (1.4 - 7.9) | 0.005 | 3.1 (1.2 - 8.2) | 0.021 |
| LVEF (Mean ± SD) | 62.6 ± 7.2 | 63.9 ± 6.2 | NA | 0.339 |
|
|